REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 52 filers reported holding REPLIMUNE GROUP INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $209,839 | -17.4% | 9,037 | -3.3% | 0.00% | 0.0% |
| Q4 2022 | $254,075 | +41.9% | 9,341 | -11.4% | 0.00% | – |
| Q1 2022 | $179,000 | -49.6% | 10,548 | -19.5% | 0.00% | -100.0% |
| Q4 2021 | $355,000 | -13.2% | 13,096 | -5.1% | 0.00% | 0.0% |
| Q3 2021 | $409,000 | -30.6% | 13,806 | -9.9% | 0.00% | -50.0% |
| Q2 2021 | $589,000 | +50.3% | 15,320 | +19.1% | 0.00% | +100.0% |
| Q1 2021 | $392,000 | -16.8% | 12,861 | +4.1% | 0.00% | -50.0% |
| Q4 2020 | $471,000 | +205.8% | 12,359 | +18.0% | 0.00% | +100.0% |
| Q2 2019 | $154,000 | -15.8% | 10,474 | -12.9% | 0.00% | 0.0% |
| Q1 2019 | $183,000 | +59.1% | 12,025 | +4.7% | 0.00% | 0.0% |
| Q4 2018 | $115,000 | – | 11,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |